TL;DR
Wedgewood Pharmacy is recalling certain compounded veterinary medications shipped to U.S. customers from Feb. 18 through Oct. 6, 2026, after identifying inconsistencies in laboratory testing data. The company says affected products could be below or above their intended potency; it reports 98 complaints, including seven classified as serious.
Wedgewood Pharmacy is recalling certain compounded veterinary medications still within their expiry dates after finding inconsistencies in laboratory testing data that may have resulted in products with too little or too much active ingredient. The medications were shipped to veterinary practices, pharmacies and other customers across the United States between Feb. 18 and Oct. 6, 2026, and the company says it has received 98 complaints, seven of them serious.
Get oils, diffusers and self-care delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The recall covers a range of compounded preparations, including powders, pastes, oral suspensions, injectables, eye and ear products, topical sprays and gels. The products are intended for companion, equine, exotic, zoo, wildlife and aquatic animals. Wedgewood says they are not intended for food-producing animals. The recall applies to particular products, lots and expiration dates, not necessarily every medication made by the pharmacy.
Wedgewood said the issue arose from inconsistencies in the reliability of certain analytical testing data generated by its laboratory. The company warned that a product with low potency could fail to provide effective treatment, while one with high potency could cause toxicity or overdose. The announcement does not identify a single active ingredient or one uniform clinical risk across all recalled products; customers must check the product and lot details against the company’s recall list.
The company said the issue was identified through its own quality processes. The FDA published Wedgewood’s announcement on Oct. 21 as a public service and stated that the recall is being conducted with the agency’s knowledge. The FDA’s notice explains that publication of a company announcement does not mean the agency endorses the product or the company.
How the Recall Could Affect Animal Care
The possible potency variation matters because veterinary treatment depends on animals receiving medicines at appropriate strengths. According to Wedgewood’s hazard statement, a dose that is weaker than intended may not treat the condition effectively, while a stronger-than-intended product could expose an animal to toxicity or overdose. The specific outcome may depend on the medication, the animal and how it was used; the announcement does not report a single effect shared by all affected products.
The distribution period and variety of preparations mean that veterinary clinics and pharmacies may need to check inventories and dispensing records, while animal owners may need to verify products they received. Wedgewood says businesses that further dispensed an affected product should identify and notify their customers. A recall does not establish that every product in the listed categories is affected, so checking the exact product, lot number and expiry date is central to acting on the notice.
Interrupting a prescribed treatment can also create care questions. Wedgewood says it is working with customers and veterinarians on continuity of care and clinically appropriate alternatives where available. Owners with concerns about an animal’s treatment are directed to contact their veterinarian rather than make a treatment decision based solely on the general recall description.
Products Worth Considering
Philips Sonicare 6500 Rechargeable Electric Toothbrush with 2 Brush Heads, White
Therabody Theragun Relief Massage Gun, 3-Speed, Navy
Oura Ring 5 Smart Ring, Silver, Size 10
As an affiliate, we earn on qualifying purchases.
Recall Scope and Customer Notices
The FDA notice identifies the event as a company-announced recall of compounded veterinary medications at the provider or customer level. Wedgewood says affected items were distributed nationwide to veterinary practices, pharmacies and other customers during the stated shipment window. The notice does not provide a single brand name for the products; it directs readers to a company lookup page for the full affected-product list, including lot numbers and expiration dates.
Wedgewood has engaged Sedgwick to coordinate the recall. According to the announcement, Sedgwick is notifying affected customers by email and mail and arranging refunds or, where possible, replacements. The company advises animal owners who received an affected product to stop using it, keep the product and contact recall services. Veterinary practices, pharmacies and other business customers are instructed to check inventory, quarantine affected products and contact the recall team.
The FDA notice also provides a channel for reporting suspected adverse reactions or product-quality problems: the agency’s Center for Veterinary Medicine can be reached at 1-888-FDA-VETS or through its online reporting form. That reporting option is separate from Wedgewood’s recall-service contact, which handles product identification and customer support.
“The recall follows “inconsistencies in the reliability of certain analytical testing data generated by their laboratory.””
— Wedgewood Pharmacy, in the company announcement reproduced by the FDA
What the Notice Does Not Specify
The public notice does not give the total number of individual products or lots affected, identify each medication in its main announcement, or explain which laboratory tests produced unreliable data. Wedgewood directs customers to its recall lookup page for the product descriptions, lot numbers and expiry dates needed to determine whether a specific item is included.
The company reports 98 complaints, including seven serious complaints, but the announcement does not describe the reported events, say whether they involved confirmed harm, or provide details about the animals’ outcomes. It also does not state how many animals or customers may have been affected. The reported figures should not be taken as a count of confirmed injuries.
The available notice does not establish whether every recalled item was under- or over-potent, by how much any product’s potency varied, or whether additional products may be added to the recall. The FDA’s publication of the company announcement is not an independent endorsement or a detailed agency assessment of each product’s risk.
Steps for Owners and Veterinary Practices
Customers should compare any Wedgewood compounded medication they have with the company’s recall lookup, checking the specific product, lot number and expiry date. Owners who find an affected item should stop using it, retain it and contact Wedgewood’s recall services through Sedgwick at 866-562-5931. The company lists phone support Monday through Friday, 8 a.m. to 9 p.m. Eastern time, and Saturday, 9 a.m. to 5 p.m. Eastern time.
Veterinary practices, pharmacies and other business customers are asked to examine stock, quarantine affected products and contact the recall team. If an affected medication has already been dispensed, Wedgewood says the business should identify and notify the customers who received it. Animal owners with medical concerns should speak with their veterinarian; the company says clinical questions referred through Sedgwick will be directed to its care team, which is working to identify alternatives where available.
The next steps described in the notice are customer notification, product checks and the arrangement of refunds or possible replacements. Customers can also report adverse reactions or quality problems to the FDA through 1-888-FDA-VETS or the agency’s online reporting form. The notice does not give a schedule for further updates, so customers should use the recall lookup and contact channels for current product-specific information.
Key Questions
Which veterinary medications are included in the recall?
The recall covers certain compounded preparations, including powders, pastes, suspensions, injectables, eye and ear products, sprays and gels. Check Wedgewood’s recall lookup for the affected product names, lot numbers and expiration dates; not every medication in those categories is necessarily included.
What should I do if my animal has an affected medication?
Wedgewood advises owners to stop using the product, retain it and contact recall services at 866-562-5931. Contact your veterinarian about treatment concerns or questions about your animal’s care.
Why did Wedgewood issue the recall?
The company says inconsistencies in the reliability of certain laboratory analytical testing data may have resulted in some products being below or above intended potency. Low potency could mean ineffective treatment; high potency could pose a toxicity or overdose risk, according to the company.
Were animals harmed by the recalled products?
Wedgewood reports receiving 98 complaints, seven classified as serious, but its announcement does not describe the complaints or confirm specific injuries or outcomes. Owners concerned about an animal should contact a veterinarian and can report suspected adverse reactions to the FDA.
How can a veterinary practice or pharmacy respond?
Businesses should check inventory against the recall list, quarantine affected products and call Wedgewood’s recall service. The company says practices or pharmacies that have already dispensed affected products should identify and notify those customers.
Source: primary
